In vitro culture of murine megakaryocytes from fetal liver-derived hematopoietic stem cells

References

• Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 1997;90(11):4369–4383.
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Historical review: megakaryopoiesis and thrombopoiesis. Blood 2008;111(3):981–986. doi:10.1182/blood-2007-05-088500
   PubMed Web of Science ®Google Scholar
• Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369(6481):568–571. doi:10.1038/369568a0
   PubMed Web of Science ®Google Scholar
• De Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369(6481):533–538. doi:10.1038/369533a0
   PubMed Web of Science ®Google Scholar
• Machlus KR, Italiano JE Jr. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 2013;201(6):785–796. doi:10.1083/jcb.201304054
   PubMed Web of Science ®Google Scholar
• Machlus KR, Thon JN, Italiano JE Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br J Haematol 2014;165(2):227–236. doi:10.1111/bjh.12758
   PubMed Web of Science ®Google Scholar
• Di Buduo CA, Soprano PM, Tozzi L, Marconi S, Auricchio F, Kaplan DL, Balduini A. Modular flow chamber for engineering bone marrow architecture and function. Biomaterials 2017;146:60–71. doi:10.1016/j.biomaterials.2017.08.006
   PubMed Web of Science ®Google Scholar
• Choi ES, Nichol JL, Hokom MM, Hornkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995;85(2):402–413.
   PubMed Web of Science ®Google Scholar
• Schipper LF, Brand A, Reniers N, Melief CJ, Willemze R, Fibbe WE. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol 2003;31(4):324–330.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Tanaka I, Kobune M, Kawano Y, Tanaka M, Kuribayashi K, Iyama S, Sato T, Sato Y, Takimoto R. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 2006;24(12):2877–2887. doi:10.1634/stemcells.2006-0309
   PubMed Web of Science ®Google Scholar
• Mattia G, Vulcano F, Milazzo L, Barca A, Macioce G, Giampaolo A, Hassan HJ. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002;99(3):888–897.
   PubMed Web of Science ®Google Scholar
• Currao M, Malara A, Di Buduo CA, Abbonante V, Tozzi L, Balduini A. Hyaluronan based hydrogels provide an improved model to study megakaryocyte-matrix interactions. Exp Cell Res 2016;346(1):1–8. doi:10.1016/j.yexcr.2015.05.014
   PubMed Web of Science ®Google Scholar
• Di Buduo CA, Wray LS, Tozzi L, Malara A, Chen Y, Ghezzi CE, Smoot D, Sfara C, Antonelli A, Spedden E, et al. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies. Blood 2015;125(14):2254–2264. doi:10.1182/blood-2014-08-595561
   PubMed Web of Science ®Google Scholar
• Thon JN, Mazutis L, Wu S, Sylman JL, Ehrlicher A, Machlus KR, Feng Q, Lu S, Lanza R, Neeves KB, et al. Platelet bioreactor-on-a-chip. Blood 2014;124:1857–1867. doi:10.1182/blood-2014-05-574913
   PubMed Web of Science ®Google Scholar
• Panuganti S, Papoutsakis ET, Miller WM. Bone marrow niche-inspired, multiphase expansion of megakaryocytic progenitors with high polyploidization potential. Cytotherapy 2010;12(6):767–782. doi:10.3109/14653241003786148
   PubMed Web of Science ®Google Scholar
• Sullenbarger B, Bahng JH, Gruner R, Kotov N, Lasky LC. Prolonged continuous in vitro human platelet production using three-dimensional scaffolds. Exp Hematol 2009;37(1):101–110. doi:10.1016/j.exphem.2008.09.009
   PubMed Web of Science ®Google Scholar
• De Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev 2005;14(4):415–424. doi:10.1089/scd.2005.14.415
   PubMed Web of Science ®Google Scholar
• Van Den Oudenrijn S, Von Dem Borne AE, De Haas M. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol 2000;28(9):1054–1061.
   PubMed Web of Science ®Google Scholar
• Reems JA, Pineault N, Sun S. In vitro megakaryocyte production and platelet biogenesis: state of the art. Transfus Med Rev 2010;24(1):33–43. doi:10.1016/j.tmrv.2009.09.003
   PubMed Web of Science ®Google Scholar
• Lu SJ, Li F, Yin H, Feng Q, Kimbrel EA, Hahm E, Thon JN, Wang W, Italiano JE, Cho J, et al. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res 2011;21(3):530–545. doi:10.1038/cr.2011.8
   PubMed Web of Science ®Google Scholar
• Takayama N, Nishikii H, Usui J, Tsukui H, Sawaguchi A, Hiroyama T, Eto K, Nakauchi H. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 2008;111(11):5298–5306. doi:10.1182/blood-2007-10-117622
   PubMed Web of Science ®Google Scholar
• Takayama N, Eto K. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells. Methods Mol Biol 2012;788:205–217. doi:10.1007/978-1-61779-307-3_15
   PubMedGoogle Scholar
• Eto K, Murphy R, Kerrigan SW, Bertoni A, Stuhlmann H, Nakano T, Leavitt AD, Shattil SJ. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling. Proc Natl Acad Sci U S A 2002;99(20):12819–12824. doi:10.1073/pnas.202380099
   PubMed Web of Science ®Google Scholar
• Nishimura T, Hatoya S, Kanegi R, Sugiura K, Wijewardana V, Kuwamura M, Tanaka M, Yamate J, Izawa T, Takahashi M, et al. Generation of functional platelets from canine induced pluripotent stem cells. Stem Cells Dev 2013;22(14):2026–2035. doi:10.1089/scd.2012.0701
   PubMed Web of Science ®Google Scholar
• Feng Q, Shabrani N, Thon JN, Huo H, Thiel A, Machlus KR, Kim K, Brooks J, Li F, Luo C, et al. Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports 2014;3(5):817–831. doi:10.1016/j.stemcr.2014.09.010
   PubMed Web of Science ®Google Scholar
• Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, Fujita K, Koike T, Harimoto K, Dohda T, et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 2014;14(4):535–548. doi:10.1016/j.stem.2014.01.011
   PubMed Web of Science ®Google Scholar
• Moreau T, Evans AL, Vasquez L, Tijssen MR, Yan Y, Trotter MW, Howard D, Colzani M, Arumugam M, Wu WH, et al. Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun 2016;7:11208. doi:10.1038/ncomms11208
   PubMed Web of Science ®Google Scholar
• Lambert MP, Sullivan SK, Fuentes R, French DL, Poncz M. Challenges and promises for the development of donor-independent platelet transfusions. Blood 2013;121(17):3319–3324. doi:10.1182/blood-2012-09-455428
   PubMed Web of Science ®Google Scholar
• Karagiannis P, Eto K. Manipulating megakaryocytes to manufacture platelets ex vivo. J Thromb Haemost 2015;13(Suppl 1):S47–53. doi:10.1111/jth.12946
   PubMed Web of Science ®Google Scholar
• Avanzi MP, Chen A, He W, Mitchell WB. Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis. Transfusion 2012;52(11):2406–2413. doi:10.1111/j.1537-2995.2012.03711.x
   PubMed Web of Science ®Google Scholar
• Lecine P, Villeval JL, Vyas P, Swencki B, Xu Y, Shivdasani RA. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 1998;92(5):1608–1616.
   PubMed Web of Science ®Google Scholar
• Machlus KR, Wu SK, Stumpo DJ, Soussou TS, Paul DS, Campbell RA, Kalwa H, Michel T, Bergmeier W, Weyrich AS, et al. Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation. Blood 2016;127(11):1468–1480. doi:10.1182/blood-2015-08-663146
   PubMed Web of Science ®Google Scholar
• Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005;115(12):3348–3354. doi:10.1172/JCI26891
   PubMed Web of Science ®Google Scholar
• Italiano JE Jr., Patel-Hett S, Hartwig JH. Mechanics of proplatelet elaboration. J Thromb Haemost 2007;5(Suppl 1):18–23. doi:10.1111/j.1538-7836.2007.02487.x
   PubMedGoogle Scholar
• Italiano JE Jr., Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999;147(6):1299–1312.
   PubMed Web of Science ®Google Scholar
• Schulze H. Culture of murine megakaryocytes and platelets from fetal liver and bone marrow. Methods Mol Biol 2012;788:193–203. doi:10.1007/978-1-61779-307-3_14
   PubMedGoogle Scholar
• Schulze H. Culture, Expansion, and Differentiation of Murine Megakaryocytes from Fetal Liver, Bone Marrow, and Spleen. Curr Protoc Immunol 2016;112:22F 6 1–F 6 15.
   Google Scholar
• Shivdasani RA, Schulze H. Culture, expansion, and differentiation of murine megakaryocytes. Curr Protoc Immunol 2005;Volume 67; Chapter 22:Unit:22F–6.
   Google Scholar